T-cell Glycosylation Patterns Influence Colitis-Associated Colorectal Cancer Risk

Overview

This study identifies branched N-glycosylation changes in colonic T cells as a dynamic mechanism influencing the progression from inflammatory bowel disease (IBD) to colitis-associated colorectal cancer (CAC). Elevated branched N-glycans in T cells correlate with impaired antitumor immunity and predict CAC development with high sensitivity and moderate specificity.

Background

Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder that significantly increases the risk of colorectal cancer, particularly colitis-associated colorectal cancer. The risk escalates with disease duration and severity of inflammation, yet molecular mechanisms driving this progression remain unclear. Glycosylation, especially branched N-glycans on T cells, modulates immune responses and has been implicated in both IBD severity and cancer progression. Understanding these glycosylation changes may reveal biomarkers for early cancer risk stratification in IBD patients.

Data Highlights

Key Findings

• Branched N-glycans on colonic T cells increase progressively from colitis through dysplasia to cancer stages in CAC development.
• This glycosylation switch imparts inhibitory properties on T cells, reducing effective antitumor immune responses.
• Mgat5 knockout mice lacking branched N-glycans show suppressed CAC development due to enhanced infiltration of CD8+ and γδ T cells.
• Branched N-glycosylation levels in inflamed IBD lesions predict CAC progression with 83.3% sensitivity and 67.9% specificity when combined with age at diagnosis.
• MGAT5 gene expression is downregulated in T cells during IBD but upregulated in cancer epithelial cells, indicating a complex role in inflammation and malignancy.

Clinical Implications

Assessment of branched N-glycosylation levels in colonic T cells may serve as a valuable biomarker to identify IBD patients at high risk for CAC development, enabling targeted surveillance and early intervention. Therapeutic strategies modulating T-cell glycosylation could enhance antitumor immunity and potentially prevent malignant transformation in chronic colitis.

Conclusion

Branched N-glycosylation alterations in colonic T cells represent a novel mechanism driving the transition from chronic inflammation to colorectal cancer in IBD patients. This glycosylation pattern holds promise as a predictive biomarker to improve cancer surveillance and guide preventive strategies in high-risk individuals.

References

1. Original Article -- T-cell Glycosylation Patterns as Influencers of Colitis-Related Colorectal Cancer Development